CN1385161A - Ointment prescription for treating trauma - Google Patents
Ointment prescription for treating trauma Download PDFInfo
- Publication number
- CN1385161A CN1385161A CN 02115904 CN02115904A CN1385161A CN 1385161 A CN1385161 A CN 1385161A CN 02115904 CN02115904 CN 02115904 CN 02115904 A CN02115904 A CN 02115904A CN 1385161 A CN1385161 A CN 1385161A
- Authority
- CN
- China
- Prior art keywords
- paraffin
- wound
- stearic acid
- prescription
- milliliter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The composition of the invented ointment prescription for curing bed sore and other external wounds is mainly composed of stearic acid, liquid paraffin, paraffin, glycerin, hexylparaben, potassium hydroxide, triethanolamine, gentamycin sulfate and isoprenaline hydrochloride. Said invention possesses the good effect of killing bacteria, relieving inflammation, arresting bleeding, supplying nutrients and astringing surface of wound.
Description
Technical field
The present invention relates to treat the medicine of wound.Particularly a kind of unguentum for the treatment of decubital ulcer and other outer surface wound.
Technical background
Before the present invention proposes, the method of traditional treatment decubital ulcer is very numerous and diverse, particularly to II more than the phase than degree of depth wound surface, mostly adopt the roasting medicine of the topped back light of the big sliver of celebrating directly to stimulate wound surface, it is wayward to add roasting light temperature, greatly damage regenerated histiocyte, destroyed the healing of new wound surface again, the serious scald that also may cause skin and wound surface; Though traditional method is to the I phase or do not have the decubital ulcer of skin ulceration, by soak or massage certain effect is arranged, the nurse job amount is big.With oiliness paste application wound surface, pollute clothes and quilt easily, when changing dressings also difficulty clean up.
Summary of the invention
The purpose of this invention is to provide a kind of have sterilization, antiinflammatory, hemostasis, can grow the ointment prescription of wound surface growth and convergence wound surface, and easy to use, can reach good curative effect.
Realize that the concrete prescription components by weight percentage of purpose of the present invention is:
Stearic acid 35-45%
Liquid paraffin 18-20%
Paraffin 8-10%
Glycerol 25-30%
Nipalgin is ester 0.1-0.3%
Potassium hydroxide 0.5-1%
Three hydramine 0.03-0.06 milliliters
Gentamycin sulfate 0.2-0.33 milliliter (1 milliliter=40,000 unit)
Isoprenaline 0.1-0.4 milliliter
The present invention carries out routine with above-mentioned prescription and mixes, and promptly makes unguentum.
The present invention has demonstrated excellent curative in clinical, the pharmacology analysis from prescription of the present invention also can fully obtain proof:
1) isoprenaline is a B epinephrine variant excitomotor, peripheral blood vessel there is dilating effect, the energy microcirculation improvement, patients with bedsore mainly is that the long-term pressurized of the skin Zhou Xunhuan of place is obstructed, but with this medicine microcirculation improvement, increase oxygen supply and nutrition supply, recover the blood supply function of pressurized tissue.
2) gentamycin sulfate is a kind of spectrum antibiotics, and gram negative bacteria and gram-positive bacterium are had the strong antibiotic effect.
3) stearic acid, paraffin, glycerol, nipalgin ester, three hydramine etc. can replenish supply effect to skin-nourishing.
4) can improve the performance of various medicines after above several drugs is prepared mutually, thereby play the effect of rapid antiinflammatory, antiinflammatory, hemostasis, nutrition supply, promote the absorption of skin, the infection of control wound surface, make the blood circulation of wound surface be able to rapid change, convergence fast, the regeneration capacity of recovery skin.
The specific embodiment
By prescription provided by the invention, preparation 10 gram wound unguentum.
Stearic acid 4 grams
Liquid paraffin 2 grams
Paraffin 1 gram
Glycerol 2.5 grams
Nipalgin is ester 0.03 gram
Potassium hydroxide 0.1 gram
Three 0.05 milliliter of hydramine
0.3 milliliter of gentamycin sulfate
0.2 milliliter of isoprenaline
After above-mentioned prescription weighing, fully mix, promptly make the wound unguentum.
Claims (1)
1, a kind of unguentum for the treatment of wound, it is made up of stearic acid, liquid paraffin, paraffin, glycerol, nipalgin ester, potassium hydroxide, three hydramine, gentamycin sulfate, isoprenaline, its component by weight percentage:
Stearic acid 35-45%
Liquid paraffin 18-20%
Paraffin 8-10%
Glycerol 25-30%
Nipalgin is ester 0.1-0.3%
Potassium hydroxide 0.5-1%
Three hydramine 0.03-0.06 milliliters
Gentamycin sulfate 0.2-0.33 milliliter
Isoprenaline 0.1-0.4 milliliter
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02115904 CN1212120C (en) | 2002-05-30 | 2002-05-30 | Ointment prescription for treating trauma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02115904 CN1212120C (en) | 2002-05-30 | 2002-05-30 | Ointment prescription for treating trauma |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1385161A true CN1385161A (en) | 2002-12-18 |
CN1212120C CN1212120C (en) | 2005-07-27 |
Family
ID=4743940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02115904 Expired - Fee Related CN1212120C (en) | 2002-05-30 | 2002-05-30 | Ointment prescription for treating trauma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1212120C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7328756B2 (en) | 2004-01-16 | 2008-02-12 | Halliburton Energy Serivces, Inc. | Settable fluids comprising particle-size distribution-adjusting agents and methods of use |
-
2002
- 2002-05-30 CN CN 02115904 patent/CN1212120C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7328756B2 (en) | 2004-01-16 | 2008-02-12 | Halliburton Energy Serivces, Inc. | Settable fluids comprising particle-size distribution-adjusting agents and methods of use |
Also Published As
Publication number | Publication date |
---|---|
CN1212120C (en) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020101591A4 (en) | A thermosensitive gel, preparation method and application thereof | |
CN1733294A (en) | Recombined human alkaline fibroblast growth factor gelling agent and process for preparing the same | |
CN106728727A (en) | It is a kind of to treat ointment of sore and preparation method thereof | |
CN103083712A (en) | Stem cells or other bioactive substances doped surgical dressing | |
CN1212120C (en) | Ointment prescription for treating trauma | |
CN112933214A (en) | Composition for promoting wound healing | |
CN106562953B (en) | Application, drug and process for preparing medicine of the hydroxyl radical carthamin yellow carthamus A in the drug of preparation treatment diabetic foot ulcer | |
CN107468715A (en) | Bacillus cercus CGMCC0601 zymotic fluids are preparing the application in treating diabetes trauma Wound medicine | |
CN107802895A (en) | A kind of scar repair material and its preparation method and application | |
CN1449823A (en) | Use of ulinastatin in treating SARS and medicinal composition thereof | |
CN1314420C (en) | Stomatocace powder | |
EP3888649B1 (en) | Cannflavin a for use in promoting wound healing and treating or preventing diabetic feet | |
CN104189304B (en) | It is a kind of to be used to treat Chinese medicine composition of surgical wound and preparation method thereof | |
CN1094765C (en) | External-use burn ointment | |
CN1175850C (en) | Medicine for treating burns and scald, and producing method thereof | |
CN104027346B (en) | Medicament composition for treating wound fester and preparation method thereof | |
CN1269510C (en) | Medicine for treating wound | |
CN1634185A (en) | Camellia oil | |
CN107158446A (en) | The hemostasis of the composite active carbon fibre of class containing only iridoid glycoside, antibacterial, promoting healing medical dressing, Preparation method and use | |
CN116474162B (en) | Preparation method of self-repairing hydrogel for repairing diabetes chronic wounds | |
CN110522766B (en) | Gel system loaded with tumor exosomes and preparation method and application thereof | |
CN1233350C (en) | Medication formulation for burn and scald | |
CN1059585C (en) | A new type scald ointment | |
CN1275616C (en) | A pharmaceutical composition for treating burn and scald | |
CN1803203A (en) | Soluble hemostatic gauze for diminishing inflammation, killing bacteria and calming pain, and its making method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050727 Termination date: 20140530 |